Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-08-30

Clinical Trial Update: Predictive Value of CHA2DS2-VASC Score and Contrast Volume to Creatinine Clearance Ratio in Relation to Mehran Score for Contrast-Induced Nephropathy In ST- Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention

View source ↗

Summary

Clinical trial assessing whether CHA2DS2-VASC score and the ratio of contrast volume to creatinine clearance can predict contrast-induced nephropathy in patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assiut University | Conditions: Contrast-induced Nephropathy | Status: UNKNOWN